Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Acute Promyelocytic Leukemia during Pregnancy: Report of 3 Cases

  • 165 Accesses

  • 24 Citations

Abstract

Acute promyelocytic leukemia (APL) is characterized by onset at a young age and a life-threatening hemorrhagic diathesis, which is attributed to a disseminated intravascular coagulation (DIC)-like coagulopathy. The discovery of all-trans-retinoic acid has changed the course of APL treatment by reducing the onset of DIC and inducing a complete and durable remission in more than 90% of patients. The occurrence of APL during pregnancy is not a frequent event, but the management of these patients raises many therapeutic and ethical dilemmas and requires a careful clinical case evaluation of fetal and maternal risk, coagulation status, the parents’ wishes, and therapeutic options. Here we describe 3 patients with APL diagnosed during pregnancy. Clinical data and the therapeutic approaches are presented. In the discussion, we analyze clinical decisions and therapeutic options and compare our cases with those found in the literature. Int J Hematol. 2004;79:31-36.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Warrell RP, de The H, Wang ZY, Degos L. Acute promyelocytic leukemia.N Engl J Med. 1993;329:177–189.

  2. 2.

    Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.Blood. 1992;79:543–553.

  3. 3.

    Speiser W, Pabinger-Fasching I, Kyrle PA, et al. Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis.Blut. 1990;61:298–302.

  4. 4.

    Degos L, Dombret H, Chomienne C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.Blood. 1995;85:2643–2653.

  5. 5.

    Warrell RP Jr, Frankel SR, Miller WH Jr, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin(all-trans- retinoic acid).N Engl J Med. 1991;324:1385–1893.

  6. 6.

    Fenaux P, Chomienne C, Degos L.All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.Semin Hematol. 2001;38:13–25.

  7. 7.

    Zuazu J, Julia A, Sierra J, et al. Pregnancy outcome in hematological malignancies.Cancer. 1991;67:703–709.

  8. 8.

    Huang ME, Ye YC, Chen SR, et al. Use ofall-trans retinoic acid in the treatment of acute promyelocytic leukemia.Blood. 1988;72:567–572.

  9. 9.

    Frankel SR, Eardley A, Lauwers G, Weiss M, Warrel RP. The “retinoic acid syndrome” in acute promyelocytic leukemia.Ann Intern Med. 1992;117:292–296.

  10. 10.

    Lipovsky MM, Biesma DH, Christiaens GCML, Petersen EJ. Successful treatment of acute promyelocytic leukemia withall-trans- retinoic-acid during late pregnancy.Br J Haematol. 1996;94:699–701.

  11. 11.

    Giagounidis AA, Beckmann MW, Giagounidis AS, et al. Acute promyelocytic leukemia and pregnancy.Eur J Haematol. 2000;64:267–271.

  12. 12.

    Incerpi MH, Miller DA, Posen R, Byrne JD.All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.Obstet Gynecol. 1997;89:826–828.

  13. 13.

    Fadilah SA, Hatta AZ, Keng CS, Jamil MA, Singh S. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid.Leukemia. 2001;15:1665–1666.

  14. 14.

    Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy.N Engl J Med. 1985;313:837–841.

  15. 15.

    Lynchberg MC, Khoury MJ, Lammer EJ, Waller KO, Cordero JF, Erickson JD. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance.Teratology. 1990;42:513–519.

  16. 16.

    Stern R. When a uniquely effective drug is teratogenic: the case of isotretinoin.N Engl J Med. 1989;320:1007–1009.

  17. 17.

    Chalmers RJ. Retinoid therapy: a real hazard for the developing embryo.Br J Obstet Gynaecol. 1992;99:276–278.

  18. 18.

    Caligiuri MA. Leukemia and pregnancy: treatment and outcome.Adv Oncol. 1992;8:10–17.

  19. 19.

    Doll DC, Ringerberg S, Yarbro JW. Antineoplastic agent and pregnancy.Semin Oncol. 1989;16:337–346.

  20. 20.

    Caligiuri MA, Mayer RY. Pregnancy and leukemia.Semin Oncol. 1989;16:388–396.

  21. 21.

    Harrison P, Chipping P, Fothergill GA. Successful use ofall-trans retinoic acid in acute promyelocytic leukemia presenting during the second trimester of pregnancy.Br J Haematol. 1994;86:681–682.

  22. 22.

    Stentoft J, Nielsen LJ, Hvidman LE.All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.Leukemia. 1994;8:1585–1588.

  23. 23.

    Watanabe R, Okamoto S, Moriki T, Kizaki M, Kawai Y, Ikeda Y. Treatment of acute promyelocytic leukemia withall-trans retinoic acid during the third trimester of pregnancy.Am J Hematol. 1995;48:210–211.

  24. 24.

    Bhoopathi B, Ostapowicz F, Bazley W. Acute promyelocytic leukemia in pregnancy.Obstet Gynecol. 1973;41:275–278.

  25. 25.

    Ewing PA, Whittaker JA. Acute leukemia in pregnancy.Obstet Gynecol. 1973;42:245–251.

  26. 26.

    Beller FK, Wagner H, Buchner T. Peripheral microthrombotic purpura associated with acute promyelocytic leukemia in pregnancy: a light and electron microscopic study [in German].Klin Wochen- schr. 1978;56:593–599.

  27. 27.

    Coser P, Prinoth O, Fabris P, Colombetti V, Mengarda G, Delucca A. Successful pregnancy in acute promyelocytic leukaemia.Haematologica. 1979;64:356–361.

  28. 28.

    Gstöttner M, Frisch H, Dienstl F. Delivery of a normal child after chemotherapy of acute promyelocytic leukaemia during pregnancy [in German].Blut. 1978;36:171–174.

  29. 29.

    Alegre A, Chunchurreta R, Rodriguez-Alarcon J, Cruz E, Prada M. Successful pregnancy in promyelocytic leukemia.Cancer. 1982;49:152–153.

  30. 30.

    Pralle H, Amberg R, Granbuer M, Loffler H. Treatment results for acute leukemias in the 22nd and 36th week of pregnancy.Blut. 1982;45:190–191.

  31. 31.

    Sanz MA, Rafecas FJ. Successful pregnancy during chemotherapy for acute promyelocytic leukemia.N Engl J Med. 1982;306:939.

  32. 32.

    Katagiri S, Tsubakio T, Minami G, et al. Successful embolization for uterine hemorrhage in a patient with acute promyelocytic leukemia.Acta Haematol. 1983;70:119–121.

  33. 33.

    Catanzarite VA, Ferguson JE 2nd. Acute leukemia and pregnancy: a review of management and outcome, 1972-1982.Obstet Gynecol Surv. 1984;39:663–678.

  34. 34.

    Fassas A, Kartalis G, Klearchou N, Tsatalas K, Sinacos Z, Mantalenakis S. Chemotherapy for acute leukemia during pregnancy: five case reports.Nouv Rev Fr Hematol. 1984;26:19–24.

  35. 35.

    Tono A, Shimokawa H, Uchino H, et al. Pregnancy complicated with acute promyelocytic leukemia: case report [in Japanese].Nippon Sanka Fujinka Gakkai Zasshi. 1986;38:131–134.

  36. 36.

    Bartsch HH, Meyer D, Teichmann AT, Speer CP. Treatment of promyelocytic leukemia during pregnancy: a case report and review of the literature.Blut. 1988;57:51–54.

  37. 37.

    D'Emilio A, Dragone P, De Negri G, Montaldi A, Stella M, Battista R. Acute myelogenous leukemia in pregnancy.Haematologica. 1989;74:601–604.

  38. 38.

    Wallace PJ. Complete remission in acute promyelocytic leukemia despite the persistence of the 15;17 translocation.Am J Hematol. 1989;31:266–268.

  39. 39.

    Takatsuki H, Abe Y, Goto T, et al. Two cases of acute promyelocytic leukemia in pregnancy and the effect of anthracyclines on fetal development [in Japanese].Rinsho Ketsueki. 1992;33:1736–1740.

  40. 40.

    Celo JS, Kim HC, Houlihan C, Canavan BF, Manzullo GP, Saidi P. Acute promyelocytic leukemia in pregnancy:all-trans retinoic acid as a newer therapeutic option.Obstet Gynecol. 1994;83:808–811.

  41. 41.

    Tsuda H, Doi H, Inada T, Shirono K. Successful treatment of acute promyelocytic leukemia in a pregnant woman by usingall-trans retinoic acid [in Japanese].Rinsho Ketsueki. 1994;35:717–719.

  42. 42.

    Morton J, Taylor K, Wright S, et al. Successful maternal and fetal outcome following the use of ATRA for the induction of APML late in the first trimester [abstract].Blood. 1995;86:772a.

  43. 43.

    Aragona M, Asmundo A. Two fatal cases of acute myeloid leukemia (M3, M4) during pregnancy [in Italian].Pathologica. 1995;87:125–134.

  44. 44.

    Simone MD, Stasi R, Venditti A, et al.All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia.Leukemia. 1995;9:1412–1413.

  45. 45.

    Nakamura K, Dan K, Iwakiri R, Gomi S, Nomura T. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid.Ann Hematol. 1995;71:263–264.

  46. 46.

    Hoffman MA, Wiernik PH, Kleiner GJ. Acute promyelocytic leukemia and pregnancy: a case report.Cancer. 1995;76:2237–2241.

  47. 47.

    Lin CP, Huang MJ, Liu HJ, Chang IY, Tsai CH. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness withall-trans retinoic acid, rhG-CSF, and erythropoietin.Am J Hematol. 1996;51:251–252.

  48. 48.

    Sham RL.All-trans retinoic acid-induced labor in a pregnant patient with acute promyelocytic leukemia [letter].Am J Hematol. 1996;53:145.

  49. 49.

    Terada Y, Shindo T, Endoh A, Watanabe M, Fukaya T, Yajima A. Fetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukemia withall-trans retinoic acid and favorable outcome.Leukemia. 1997;11:454–455.

  50. 50.

    Maeda M, Tyugu H, Okubo T, Yamamoto M, Nakamura K, Dan K. A neonate born to a mother with acute promyelocytic leukemia treated byall-trans retinoic acid [in Japanese].Rinsho Ketsueki. 1997;38:770–775.

  51. 51.

    Breccia M, Cimino G, Alimena G, De Carolis S, Lo Coco F, Mandelli F. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.Haematologica. 2002;87:ELT12.

  52. 52.

    Carradice D, Austin N, Bayston K, Ganly PS. Successful treatment of acute promyelocytic leukaemia during pregnancy.Clin Lab Haematol. 2002;24:307–311.

  53. 53.

    Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomy opathy in a newborn exposed to idarubicin and all-transretinoic acid (ATRA) early in the second trimester of pregnancy.Int J Gynecol Cancer. 2002;12:399–402.

Download references

Author information

Correspondence to Ugo Consoli or Amalia Figuera or Giuseppe Milone or Carmela Rita Meli or Giulia Guido or Francesco Indelicato or Gaetano Moschetti or Salvatore Leotta or Antonella Tornello or Massimo Poidomani or Pamela Murgano or Valeria Pinto or Rosario Giustolisi.

About this article

Cite this article

Consoli, U., Figuera, A., Milone, G. et al. Acute Promyelocytic Leukemia during Pregnancy: Report of 3 Cases. Int J Hematol 79, 31–36 (2004). https://doi.org/10.1007/BF02983530

Download citation

Key words

  • APL
  • ATRA
  • Pregnancy